Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RP4010 |
Synonyms | |
Therapy Description |
RP4010 is an inhibitor of the calcium release activated calcium channel (CRAC) that prevents calcium signaling and transcription of downstream genes to prevent tumor growth (AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr B127, PMID: 29908962). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RP4010 | RP 4010|RP-4010 | RP4010 is an inhibitor of the calcium release activated calcium channel (CRAC) that prevents calcium signaling and transcription of downstream genes to prevent tumor growth (AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr B127, PMID: 29908962). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03119467 | Phase I | RP4010 | Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | Terminated | USA | AUS | 0 |